News

XRP futures debut on CME as top analyst predicts a $10 XRP price rally and major upside for FloppyPepe (FPPE).
Following the latest results, CME Group's 14 analysts are now forecasting revenues of US$6.27b in 2025. This would be a satisfactory 2.3% improvement in revenue compared to the last 12 months ...
Additional headwinds could stem from a shift in analyst sentiment, given seven of the 13 in coverage still carry a "strong buy" rating on CME. In addition, the 12-month consensus target price of ...
The Zacks Consensus Estimate for CME's full-year earnings has moved 6.9% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
WEST LAFAYETTE, Ind., June 3, 2025 /PRNewswire/ -- Farmer sentiment improved for the second consecutive month in May, reaching its highest level since May 2021. The Purdue University/CME Group Ag ...
CME Group (NASDAQ:CME – Free Report) had its target price increased by Barclays from $263.00 to $279.00 in a research note published on Monday,Benzinga reports. The firm currently has an equal ...
Exploring Analyst Ratings: An In-Depth Overview An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Gr.
According to data from Schaeffer's Senior Quantitative Analyst Rocky White, CME Group stock is within one standard deviation of its 50-day moving average.
CME Group pays a high dividend yield, with potential for special dividends, giving it a sneaky-high yield. See why I rate CME stock as a buy.
Analyst Price Forecast Suggests 0.48% Upside As of March 4, 2025, the average one-year price target for CME Group is $263.60/share. The forecasts range from a low of $202.00 to a high of $304.50.